Bilhi Genetics Overview

  • Founded

  • 2012

Founded
  • Status

  • Private

  • Employees

  • 11

Employees
  • Latest Deal Type

  • Later Stage VC

  • Investors

  • 10

Bilhi Genetics General Information

Description

Developer of a genetic diagnostic technology designed to prevent cancer by identifying patients susceptible to developing serious illnesses before they occur. The company's genetic predictive technologies help to prevent fibrosis, cirrhosis, and cancers and enhance medical care, enabling physicians to diagnose and prevent cancer.

Contact Information

Website
www.bilhigenetics.com
Formerly Known As
GenePred
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Primary Office
  • 60 avenue Andre Roussin
  • CEDEX 16
  • 13321 Marseille
  • France
+33 04 00 00 00 00

Bilhi Genetics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bilhi Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Jan-2022 00.000 Completed Generating Revenue
7. Later Stage VC 19-Aug-2020 00000 00.000 0000 Completed Generating Revenue
6. Later Stage VC 18-Dec-2017 00.000 00.00 000.00 Completed Generating Revenue
5. Early Stage VC 01-Jul-2016 00000 00000 00.000 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2016 00.000 Completed Startup
3. Equity Crowdfunding 03-Jul-2015 00.000 00.000 Completed Startup
2. Grant $93.4K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Bilhi Genetics’s complete valuation and funding history, request access »

Bilhi Genetics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary Shares 000,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary Shares 22,348 $1.175539 $23.49 $23.49 1x $23.49 67.04%
To view Bilhi Genetics’s complete cap table history, request access »

Bilhi Genetics Executive Team (6)

Name Title Board Seat Contact Info
Pierre Dessein Co-Founder, Chief Executive Officer, President & Chairman
Stephane Lucchini Ph.D Chief Operating Officer
Alain Dessein Ph.D Co-Founder & Chief Strategy Officer
Bruno Dessein Co-Founder
You’re viewing 4 of 6 executive team members. Get the full list »

Bilhi Genetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bilhi Genetics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CapHorn Invest Venture Capital Minority 000 0000 000000 0
Sygma Accelerator/Incubator Minority 000 0000 000000 0
Colombe Investments Venture Capital Minority 000 0000 000000 0
Lise Invest Corporation Minority 000 0000 000000 0
Montgrand Wealth Partner Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial